Ekso Bionics Holdings, Inc. (EKSO) Earnings History
Annual and quarterly earnings data from 2013 to 2025
Loading earnings history...
EKSO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
EKSO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 53.5% | -104.1% | -91.4% |
| 2024 | 53.1% | -58.4% | -63.2% |
| 2023 | 49.7% | -82.7% | -83.1% |
| 2022 | 48.1% | -120.5% | -116.8% |
| 2021 | 60.0% | -123.0% | -86.8% |
Download Data
Export EKSO earnings history in CSV or JSON format
Free sign-in required to download data
Ekso Bionics Holdings, Inc. (EKSO) Earnings Overview
As of May 8, 2026, Ekso Bionics Holdings, Inc. (EKSO) reported trailing twelve-month net income of -$16M, reflecting -776.8% year-over-year growth. The company earned $-4.40 per diluted share over the past four quarters, with a net profit margin of -91.4%.
Looking at the long-term picture, EKSO's historical earnings data spans multiple years. The company achieved its highest annual net income of -$12,292 in fiscal 2013.
Ekso Bionics Holdings, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including IRBT (-$209M net income, -21.3% margin), CYBR (-$147M net income, -10.8% margin), ATAI (-$154M net income, -48464.0% margin), EKSO has room to improve margins relative to the peer group. Compare EKSO vs IRBT →
EKSO Earnings vs Peers
Earnings metrics vs comparable public companies
EKSO Historical Earnings Data (2013–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$12M | -3.2% | -$13M | $-4.91 | -91.4% | -104.1% |
| 2024 | -$11M | +25.5% | -$10M | $-0.56 | -63.2% | -58.4% |
| 2023 | -$15M | -0.8% | -$15M | $-1.10 | -83.1% | -82.7% |
| 2022 | -$15M | -54.4% | -$16M | $-1.16 | -116.8% | -120.5% |
| 2021 | -$10M | +38.3% | -$14M | $-0.88 | -86.8% | -123.0% |
| 2020 | -$16M | -30.4% | -$13M | $-2.21 | -178.2% | -144.8% |
| 2019 | -$12M | +55.1% | -$17M | $-2.44 | -87.2% | -119.6% |
| 2018 | -$27M | +7.3% | -$27M | $-6.61 | -238.2% | -238.5% |
| 2017 | -$29M | -24.1% | -$32M | $-12.27 | -396.1% | -429.9% |
| 2016 | -$23M | -19.8% | -$28M | $-18.90 | -165.0% | -194.0% |
See EKSO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EKSO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare EKSO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonEKSO — Frequently Asked Questions
Quick answers to the most common questions about buying EKSO stock.
Is EKSO growing earnings?
EKSO EPS fell to $-4.40, with earnings declining -776.8%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-16M.
What are EKSO's profit margins?
Ekso Bionics Holdings, Inc. net margin is -91.4%, with operating margin at -104.1%. Below-average margins reflect competitive or cost pressures.
How consistent are EKSO's earnings?
EKSO earnings data spans 2013-2025. The declining earnings trend is -776.8% YoY. Historical data enables comparison across business cycles.